Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: An open randomised trial

BMJ (Online)

Volumn 340, Issue 7744, 2010, Pages 460-

  McCaffery, Kirsten J ^a   Irwig, Les ^a   Turner, Robin ^a   Chan, Siew Foong ^a   Macaskill, Petra ^a   Lewicka, Mary ^a   Clarke, Judith ^a   Weisberg, Edith ^b   Barratt, Alex ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Sydney Centre for Reproductive Health Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; AUSTRALIA; CANCER RISK; CLINICAL TRIAL; COGNITION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; EMERGENCY HEALTH SERVICE; FAMILY PLANNING; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT INFORMATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RURAL AREA; SCREENING TEST; SEXUAL BEHAVIOR; SOCIAL PSYCHOLOGY; STATE TRAIT ANXIETY INVENTORY; URBAN AREA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANXIETY; COGNITION DISORDERS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PERCEPTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77649224679     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4491     Document Type: Article

References (40)

1. TOMBOLA. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 2009;339:b2549.
2. Franco EL. Managing low grade and borderline cervical abnormalities. BMJ 2009;339:b3014.
3. National Health Service Information Centre for health and social care. Cervical Screening Programme, England 2007-08, 2008. www.ic.nhs.uk/statistics- and-data-collections/screening/cervical-screening/cervical-screening-programme- england-2008-09.
4. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 2006;332:83-5.
5. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004;328:1293-8.
6. Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol 1990;97:859-61.
7. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004;111:1437-43.
8. McCaffery KJ, Waller J, Nazroo JN, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect 2006;82:69-74.
9. Irwig L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: implications for evaluation. BMJ 2006;332:1148-50.
10. Raffle AE. Informed participation in screening is essential. BMJ 1997;314:1762-3.
11. Entwistle VA, Carter SM, Trevena L, Flitcroft K, Irwig L, McCaffery K, et al. Communicating about screening. BMJ 2008;337:a1591.
12. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;(2):CD001431.
13. McCaffery K, Irwig L, Bossuyt P. Patient decision AIDS to support clinical decision making: evaluating the decision or the outcomes of the decision. Med Decis Making 2007;27:619-25.
14. McCaffery KJ, Irwig L, Chan SF, Macaskill P, Barratt A, Lewicka M, et al. HPV testing versus repeat Pap testing for themanagement of aminor abnormal Pap smear: evaluation of a decision aid to support informed choice. Patient Educ Couns 2008;73:473-9, 81.
15. O'Connor AM, Tugwell P, Wells GA, Elmsie T, Jolly E, Bunn H, et al. The Ottawa Decision Support Framework (DSF) Guiding the development of decision aids for patients and practitioners considering health care interventions. 1998.
16. ASCUS-LSIL Triage Study (ALTS Group). Results of a randomized trial on themanagement of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
17. ASCUS-LSIL Triage Study (ALTS Group). A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
18. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000;44:726-42.
19. National Health and Medical Research Council. Screening to prevent cervical cancer: guidelines for the management of women with screen detected abnormalities. In: Service AGP, ed. Canberra: Commonwealth Department of Human Services and Health, 1994.
20. Bossuyt P, McCaffery K. Additional Pathways and Outcomes in Evaluations of Testing. Medical Decision Making 2009;29:E30-8.
21. Ware J, Kosinski M, Keller S. SF-36 health survey manual and interpretation guide. 2nd ed. The Health Institute, New England Medical Centre, 1994.
22. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health 1994;48:65-73.
23. Wardle J, Pernet A, Stephens D. Psychological consequences of positive results in cervical cancer screening. Psychol Health 1995;10:185-94.
24. Horowitz M, Wilner, N, Alvarez, MA. Impact of Event Scale: Ameasure of subjective stress. Psychosom Med 1979;41:209-18.
25. Ware J, Sydner MK., Wright, WR. Development and validation of scales to measure patient satisfaction with healthcare services. University of Illinois, 1976.
26. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31(Pt 3):301-6.
27. Bennetts A, Irwig L, Oldenburg B, Simpson JM, Mock P, Boyes A, et al. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal Pap smear. J Clin Epidemiol 1995;48:1235-43.
28. Rosenberg M. Society and the adolescent self-image. Princeton University Press, 1965.
29. Campion MJ, Brown JR, McCance DJ, Atia W, Edwards R, Cuzick J, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988;95:175-81.
30. Satterthwaite FW. An approximate distribution of estimates of variance components. Biometrics Bull 1946;2:110-14.
31. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ 2009;338:a3006.
32. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-9.
33. Australian Bureau of Statistics. National Health Survey SF 36 population Norms. Australia. Canberra: ABS Catalogue Number 4399.0, 1997.
34. Sanson-Fisher R, Perkins, JJ. Adaption and validation of the SF-36 health survey for use in Australia. J Clin Epidemiol 1998;51:961-7.
35. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. Br J Cancer 2005;92:990-4.
36. Feise RJ. Domultiple outcomemeasures require p-value adjustment? BMC Med Res Methodol 2002;2:8.
37. Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P. The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial. Int J Gynecol Cancer 2008;18:743-8.
38. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003;79:320-2.
39. Waller J, McCaffery K, Nazroo J, Wardle J. Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer 2005;92:265-70.
40. Kitchener HC, Burns S, Nelson L, Myers AJ, Fletcher I, Desai M, et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. Br J Obstet Gynaecol 2004;111:63-70.